EMVision Medical Devices (ASX: EMV) Share Price and News

Dr Dubois is nuclear imaging specialist, and former CEO of their imaging division and served as Executive Director. He is also the founder and former CEO and Chairman of Queensland X Ray. He is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice President of the Australian Diagnostic Imaging Association. He is Chair of Clinical Advisory Board.

Mr Keane is an experienced business and finance executive and holds a number of independent non executive director and advisory board roles. He also undertakes finance advisory and consultancy assignments for various business clients and previously held numerous roles with a major trading bank principally in business, corporate and institutional banking. He is currently an Independent Non Executive Director and Chairman of National Storage Holdings Ltd, the holding company established for National Storage REIT, the first independent, internally managed and fully integrated owner and operator of self storage centres listed on the ASX. He is chair of the risk committee.

Mr Keep has public company board and senior management experience in the healthcare and hospitality sectors including both medical diagnostic companies and start up enterprises. Previously Chief Executive of Queensland Diagnostic Imaging, one of Queenslands most successful radiology and diagnostic imaging groups and later as Director of Operations at Lemarne Healthcare, a company specializing in the diagnosis and treatment of skin cancer. He was previously Company Secretary of Castlemaine Tooheys Limited which had a market capitalization on the ASX of $1.2 Billion prior to its takeover. He is member of the risk committee.

Mr Kirkland has held several senior sales and marketing positions, including Head of Client Sales at Quantcast, a US based AI technology company, prior to establishing EMVision as a leader in innovative neurodiagnostic technology.

Mr Kania is a medical device executive with over 20 years of commercialisation and leadership experience in medical devices, pharma and health technologies working across the US, Europe and APAC, within sales and marketing management, and general management roles. Currently he is CEO and President USA of Field Orthopaedics Ltd. and has previously held senior roles at Smith Nephew, Abbott, J&J Medical and Roche. He is member of the risk committee.

Ms Monaghan is a healthcare leader. She has worked across hospital, corporate and global positions at Ramsay for almost three decades. Prior to her appointment as CEO of Ramsay Australia, she was the Group Chief of Staff of Ramsays global operations, gaining experience and a comprehensive understanding of health care operations and strategy both in Australia and overseas. She also served as the Group Head of Marketing and Public Affairs, driving marketing, brand and communications strategy, during which the group grew to become one of the leading private healthcare operators globally.

-

-